PodParley PodParley
PodParley
For patients with nonvalvular atrial fibrillation, a key question has emerged beyond stroke prevention: does our choice of direct oral anticoagulant, or DOAC, influence long-term dementia risk? A landmark study provides a clear answer. episode artwork

EPISODE · Jun 30, 2026 · 1 MIN

For patients with nonvalvular atrial fibrillation, a key question has emerged beyond stroke prevention: does our choice of direct oral anticoagulant, or DOAC, influence long-term dementia risk? A landmark study provides a clear answer.

from TheBrief.Health · host TheBrief.Health

New baby food rules require public testing for lead, arsenic, cadmium, and mercury, improving transparency, guiding safer choices, and encouraging manufacturers to reduce contamination.

Episode metadata supplied by the publisher feed · Published Jun 30, 2026

Embed this episode

Ready to play

For patients with nonvalvular atrial fibrillation, a key question has emerged beyond stroke prevention: does our choice of direct oral anticoagulant, or DOAC, influence long-term dementia risk? A landmark study provides a clear answer.

0:00 1:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Is Vegan Diet Harming Your Brain? DHA, Salt, Stroke & Dementia Science

Sep 30, 2025 ·32m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on June 30, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!